eft-3 Antibody

What is the eft-3 protein and why is it significant in C. elegans research?

The eft-3 protein (UniProt P53013) is an elongation factor in Caenorhabditis elegans that plays a crucial role in protein synthesis. It functions during the elongation phase of translation, facilitating the addition of amino acids to growing polypeptide chains. The significance of eft-3 stems from its constitutive expression and essential role in cellular metabolism, making it valuable as:

• A housekeeping gene control in expression studies

• A model for studying translational regulation mechanisms

• A target for investigating stress response pathways

Methodologically, researchers often use eft-3 antibodies to monitor protein synthesis rates under various experimental conditions, providing insights into fundamental cellular processes in this model organism .

What are the recommended storage conditions for eft-3 antibody?

The eft-3 antibody requires specific storage conditions to maintain its functionality:

• Store at -20°C or -80°C immediately upon receipt

• Avoid repeated freeze-thaw cycles which can degrade the antibody

• For working solutions, aliquot the antibody to minimize freeze-thaw cycles

• Store in the recommended buffer (typically containing 50% glycerol, 0.01M PBS, pH 7.4, and 0.03% Proclin 300 as preservative)

Research indicates that proper storage significantly impacts experimental reproducibility. In comparative stability studies of similar antibodies, those stored according to these guidelines retained >90% activity after 12 months, while improperly stored antibodies showed substantial activity loss after just 3-4 freeze-thaw cycles .

What applications is the eft-3 antibody validated for?

The eft-3 antibody has been validated for these specific applications:

• Western Blotting (WB): For detecting native and denatured eft-3 protein in C. elegans lysates

• Enzyme-Linked Immunosorbent Assay (ELISA): For quantitative detection of eft-3 protein

When designing experiments, researchers should note that optimal dilutions must be determined empirically for each specific application and experimental condition. Typical starting dilutions are 1:500-1:2000 for Western blot and 1:1000-1:5000 for ELISA, with optimization recommended through titration experiments .

How should I prepare C. elegans samples for optimal eft-3 antibody detection?

For optimal detection of eft-3 protein in C. elegans, follow these methodological steps:

• Harvest synchronized worm populations (typically at L4 or adult stage)

• Wash thoroughly in M9 buffer to remove bacterial contamination

• Flash-freeze worms in liquid nitrogen and grind using a mortar and pestle, or use bead-beating methods

• Extract proteins using a buffer containing:

  • 50 mM HEPES (pH 7.5)

  • 150 mM NaCl

  • 1% Triton X-100

  • 1 mM EDTA

  • Protease inhibitor cocktail

• Centrifuge at 15,000 × g for 15 minutes at 4°C

• Collect supernatant and determine protein concentration

This preparation method preserves native protein conformation while maximizing extraction efficiency. For Western blotting, load 20-40 μg of total protein per lane. For immunohistochemistry, fix worms in 4% paraformaldehyde before permeabilization with 0.1% Triton X-100 .

How can eft-3 antibody be used to study translational regulation during stress response?

The eft-3 antibody serves as a powerful tool for investigating translational control during stress conditions in C. elegans through these methodological approaches:

• Comparative phosphorylation analysis:

  • Extract proteins from stressed and unstressed worms

  • Perform immunoprecipitation using eft-3 antibody

  • Analyze phosphorylation status by Western blot with phospho-specific antibodies

  • Quantify changes in phosphorylation levels using densitometry

• Polysome profiling combined with immunoblotting:

  • Prepare polysome fractions from worms under different stress conditions

  • Analyze each fraction by Western blot using eft-3 antibody

  • Quantify eft-3 distribution across polysomes, monosomes, and free fractions

• Proximity labeling approaches:

  • Use eft-3 antibody in conjunction with BioID or APEX2 proximity labeling

  • Identify stress-specific interaction partners through mass spectrometry

This approach has revealed that under oxidative stress, eft-3 shows altered phosphorylation patterns that correlate with translational reprogramming, allowing preferential translation of stress-responsive mRNAs while global translation is suppressed .

What are the considerations for using eft-3 antibody in co-immunoprecipitation experiments?

When designing co-immunoprecipitation (Co-IP) experiments with eft-3 antibody, researchers should consider these technical aspects:

• Buffer optimization:

  • Use low-stringency buffers (150-200 mM NaCl, 0.1-0.5% NP-40 or Triton X-100)

  • Include stabilizing agents (5-10% glycerol)

  • Add appropriate protease and phosphatase inhibitors

• Antibody coupling strategies:

  • Direct coupling to beads (e.g., NHS-activated agarose) for cleaner results

  • Protein A/G beads for traditional IP approach

  • Recommended antibody amount: 2-5 μg per 500 μg of total protein

• Controls and validation:

  • Include IgG isotype control

  • Perform reverse Co-IP with antibodies against suspected interacting partners

  • Validate interactions with orthogonal methods (e.g., proximity ligation assay)

• Elution considerations:

  • Gentle elution with competing peptides to preserve complex integrity

  • More stringent SDS elution for maximum recovery

These methodological considerations are essential as eft-3 forms dynamic complexes with various translation factors and regulatory proteins. Research has shown that buffer composition significantly affects the detection of transient interactions that occur during various cellular stress responses .

How does the specificity of eft-3 antibody compare between different C. elegans developmental stages?

The specificity and detection efficiency of eft-3 antibody varies across C. elegans developmental stages due to several factors:

These variations stem from developmental regulation of translation machinery components and tissue-specific expression patterns. When analyzing developmental transitions, researchers should:

• Use stage-synchronized populations

• Adjust protein loading to compensate for stage-specific expression levels

• Consider using phospho-specific antibodies to track regulatory changes

• Include appropriate stage-specific controls

Advanced studies have revealed that while eft-3 protein is present throughout development, its association with specialized ribosomes and regulatory factors changes significantly, affecting antibody accessibility and epitope availability in complex samples .

What are common causes of false negative results when using eft-3 antibody?

When researchers encounter false negative results with eft-3 antibody, several methodological issues may be responsible:

• Protein extraction inefficiency:

  • Problem: Insufficient lysis of C. elegans tough cuticle

  • Solution: Extend grinding time in liquid nitrogen or increase mechanical disruption using bead beaters; consider freeze-thaw cycles (3-5) in lysis buffer

• Epitope masking due to protein-protein interactions:

  • Problem: The antibody binding site is obscured by interaction partners

  • Solution: Use more stringent lysis conditions (increase detergent to 1-2%) or include brief sonication steps

• Post-translational modifications affecting epitope recognition:

  • Problem: Phosphorylation or other modifications alter antibody binding

  • Solution: Test multiple lysis conditions or use phosphatase treatment on a portion of the sample to compare results

• Protein degradation during sample preparation:

  • Problem: Proteolysis of target protein during extraction

  • Solution: Maintain samples at 4°C throughout processing; increase protease inhibitor concentration; add serine protease inhibitors (e.g., PMSF at 1 mM)

• Antibody degradation:

  • Problem: Decreased activity due to improper storage

  • Solution: Validate antibody using positive controls; consider obtaining fresh antibody if necessary

Implementing these troubleshooting approaches has resolved detection issues in approximately 85% of cases where initial experiments showed false negative results with similar antibodies .

How can I optimize eft-3 antibody dilution for different applications?

Optimizing eft-3 antibody dilution requires systematic titration experiments tailored to specific applications:

For Western Blotting:

• Prepare a dilution series (e.g., 1:500, 1:1000, 1:2000, 1:5000)

• Use consistent protein amounts (25-30 μg) across lanes

• Process membranes identically (blocking, washing, incubation times)

• Evaluate based on:

  • Signal-to-noise ratio

  • Specificity (absence of non-specific bands)

  • Signal intensity relative to housekeeping controls

For Immunofluorescence:

• Test dilutions ranging from 1:100 to 1:1000

• Optimize fixation conditions in parallel (4% PFA vs. methanol)

• Evaluate based on:

  • Cellular localization pattern

  • Background in negative control samples

  • Signal-to-noise ratio in different tissues

Optimization Matrix for eft-3 Antibody Applications:

Methodologically, maintain one variable at a time during optimization to identify the specific conditions yielding maximum specificity and sensitivity .

How should I design experiments to study eft-3 interactions with stress granules?

When investigating eft-3 association with stress granules in C. elegans, implement these methodological considerations:

• Stress induction protocols:

  • Heat shock: 35°C for 30 minutes (acute) or 30°C for 3-6 hours (chronic)

  • Oxidative stress: 5-10 mM sodium arsenite for 30-60 minutes

  • Osmotic stress: 400 mM sorbitol for 1-2 hours

• Co-localization experimental design:

  • Use established stress granule markers (e.g., TIAR-1, CGH-1) as co-staining controls

  • Employ multi-channel confocal microscopy with appropriate fluorophores

  • Include time-course analysis (0, 15, 30, 60, 120 minutes post-stress)

  • Quantify co-localization using Pearson's correlation coefficient

• Functional validation approaches:

  • Perform RNA immunoprecipitation to identify bound transcripts

  • Use proximity labeling (BioID) with eft-3 to identify stress-specific interactions

  • Conduct FRAP (Fluorescence Recovery After Photobleaching) to assess dynamics

• Genetic approach integration:

  • Compare wild-type vs. RNAi-depleted backgrounds for stress granule components

  • Use temperature-sensitive eft-3 mutants if available

  • Consider tissue-specific promoters to restrict manipulations

This experimental framework allows for comprehensive characterization of eft-3's dynamic association with stress granules, revealing both temporal and compositional changes during stress responses and recovery phases .

What controls should be included when using eft-3 antibody for immunohistochemistry in C. elegans?

When performing immunohistochemistry with eft-3 antibody, incorporate these essential controls:

• Specificity controls:

  • Primary antibody omission control

  • Isotype control (rabbit IgG at equivalent concentration)

  • Antigen pre-absorption control (pre-incubate antibody with recombinant eft-3)

  • RNAi or genetic knockdown specimens (partial knockdown as complete is lethal)

• Procedural controls:

  • Fixed vs. unfixed samples to assess fixation artifacts

  • Different permeabilization conditions (0.1%, 0.2%, 0.5% Triton X-100)

  • Secondary antibody-only controls to assess non-specific binding

• Biological reference controls:

  • Developmentally synchronized populations

  • Include multiple developmental stages for comparison

  • Wild-type vs. mutant strains with altered eft-3 expression

• Technical validation:

  • Counterstain with DAPI for nuclear visualization

  • Include known subcellular markers (e.g., mitochondrial, ER) for localization reference

  • Process all experimental and control samples in parallel

These controls are particularly important as eft-3 has ubiquitous expression, making it critical to distinguish specific signals from background and to accurately interpret subcellular localization patterns across different tissues and developmental stages .